Featured
Read our handpicked blogs, curated for you.
|
CMOs do not struggle to justify campaigns; they struggle to prove Marketing ROI with hard numbers the board trusts. If…
|
Pharma marketers in India know the frustration well. Campaigns stall not because the idea is weak, but because the…
|
For Indian pharma, HCP engagement is no longer about reach; it’s about relevance and measurable impact. Boards want to…
Recent releases
|
Why Field Force Enablement Needs to Be MarTech’s Next Frontier
Here's the overlooked truth: in Indian pharma boardrooms, digital transformation usually gets framed around CRM platforms, doctor engagement dashboards, or omnichannel campaigns. But let’s be…
|
10 MarTech for Pharma Metrics That Actually Matter in Pharma Marketing in 2025
Moving past vanity metricsPharma CMOs in India have had enough of dashboards cluttered with “likes,” “clicks,” and “reach.” Those numbers look good in quarterly reviews, but they don’t answer the…
|
Why CMOs Are Tired of Pilots and Want Systems That Scale
Talk to any pharma CMO in India and you’ll hear the same story. Everyone wants to sell them a pilot. A chatbot pilot. An omnichannel pilot. A CRM pilot. After two quarters of experimenting, the…
|
The Link Between Doctor Engagement and Prescription Uptake: Data Speaks
Why engagement is the real battleground: Every pharma company in India wants the same outcome: higher prescription uptake. The problem is, too many still think of it as a sales rep issue. Send more…
